Dr. Luying Liu 刘鲁迎
Chief Physician
Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive treatment of rectal, gastric, and prostate cancers; intensity-modulated radiation therapy for prostate cancer; radiotherapy for liver cancer; and management of lymphoma and soft tissue tumors.
Dr. Liu graduated from Bethune Medical University in July 1996 and has worked in oncology radiotherapy since. Research focuses on abdominal-pelvic tumors, lymphoma, and soft tissue tumors. Dr. Liu treats approximately 500 cases annually, has published over 10 papers, and participated in two Zhejiang Provincial Health Department projects.
Name order: in Chinese the family name comes first (Liu Luying). Papers usually list the name as Luying Liu or Liu L.
Selected publications
38 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- In Vitro Cell Dev Biol Anim, 2025 (senior author): LncRNA PVT1 promotes proliferation and migration in gallbladder adenocarcinoma by modulating miR-2355-5p/AGO1 axis. PubMed 40346419
- Discov Oncol, 2022 (senior author): Programmed death-ligand 1 and mammalian target of rapamycin signaling pathway in locally advanced rectal cancer. PubMed 35201501
- BMC Cancer, 2020 (senior author): Biplane transrectal ultrasonography plus ultrasonic elastosonography and contrast-enhanced ultrasonography in T staging of rectal cancer. PubMed 32894078
- J Cancer, 2019 (senior author): Perineural and lymphovascular invasion predicts for poor prognosis in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery. PubMed 31258728
- BMC Cancer, 2018 (senior author): A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report. PubMed 30134855
- Med Sci Monit, 2017 (senior author): Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. PubMed 28100902
- Int J Clin Exp Pathol, 2015 (senior author): CA724 is a novel factor for predicting the unresectability in pancreatic adenocarcinoma. PubMed 26823852
- Oncol Lett, 2015 (senior author): Zinc finger protein X-linked is overexpressed in colorectal cancer and is associated with poor prognosis. PubMed 26622575
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion